These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15033641)

  • 1. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases.
    O'Brien KL; Santosham M
    Am J Epidemiol; 2004 Apr; 159(7):634-44. PubMed ID: 15033641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possibility of application of new pneumococcal conjugate vaccines in children in Slovenia.
    Paragi M; Kolman J; Kraigher A; Cizman M; Gubina M; Ribic H;
    Vaccine; 2003 Dec; 21(32):4708-14. PubMed ID: 14585680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres.
    Malfroot A; Verhaegen J; Dubru JM; Van Kerschaver E; Leyman S
    Clin Microbiol Infect; 2004 Sep; 10(9):797-803. PubMed ID: 15355410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.
    Darkes MJ; Plosker GL
    Paediatr Drugs; 2002; 4(9):609-30. PubMed ID: 12175274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conjugate vaccine for the prevention of pediatric pneumococcal disease.
    Murray D; Jackson C
    Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New pneumococcal vaccine].
    Gaudelus J
    Bull Acad Natl Med; 2003; 187(8):1477-86; discussion 1486-8. PubMed ID: 15146579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
    Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
    Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children.
    Esposito S; Principi N
    J Immunol Res; 2015; 2015():591580. PubMed ID: 26351648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine.
    Gruber WC; Scott DA; Emini EA
    Ann N Y Acad Sci; 2012 Aug; 1263():15-26. PubMed ID: 22830997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis.
    Overturf GD
    Pediatrics; 2000 Aug; 106(2 Pt 1):367-76. PubMed ID: 10920170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccine.
    Ledwith M
    Curr Opin Pediatr; 2001 Feb; 13(1):70-4. PubMed ID: 11176248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugated vaccine: PHiD-CV.
    Dinleyici EC; Yargic ZA
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1063-74. PubMed ID: 19883326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.